[1]
|
K. B. Bechman and B. N. Ames, “Oxidative Decay of DNA,” The Journal of Biological Chemistry, Vol. 272, No. 32, 1997, pp. 633-636.
|
[2]
|
O. Ben-Yoseph and B. D. Ross, “Oxidation Therapy: The Use of a Reactive Oxygen Species-Generating Enzyme System for Tumor Treatment,” British Journal of Cancer, Vol. 70, 1994, pp. 1131-1135. doi:10.1038/bjc.1994.460
|
[3]
|
L. D. Stegman, H. Zheng, E. R. Neal, O. Ben-Yoseph, L. Pollegioni, M. Pilone and B. D. Ross, “Induction of Cytotoxic Oxidative Stress by D-Alanine in Brain Tumor Cells Expressing Rhodotorula gracilis: A Cancer Gene Therapy Strategy,” Human Gene Therapy, Vol. 9, No. 2, 1998, pp. 185-193. doi:10.1089/hum.1998.9.2-185
|
[4]
|
B. S. Berlett and E. R. Stadtman, “Protein Oxidation in Aging, Disease, and Oxidative Stress,” The Journal of Biological Chemistry, Vol. 272, No. 33, 1997, pp. 20313-20316. doi:10.1074/jbc.272.33.20313
|
[5]
|
B. Halliwell and J. M. Gutteridge, “Free Radicals, Lipid Peroxidation, and Cell Damage,” The Lancet, Vol. 324, No. 8411, 1984, p. 1095.
doi:10.1016/S0140-6736(84)91530-7
|
[6]
|
T. Matsura, M. Kai, Y. Fujii and K. Yamada, “Hydrogen Peroxide-Induced Apoptosis in HL-60 Cells Requires Caspase-3 Activation,” Free Radical Research, Vol. 30, No. 1, 1999, pp. 73-83. doi:10.1080/10715769900300081
|
[7]
|
H. Yamakawa, Y. Ito, T. Naganawa, Y. Banno, S. Nakashima, S. Yoshimura, M. Sawada, Y. Nishimura, Y. Nozawa and N. Sakai, “Activation of Caspase 9 and 3 during H2O2-Induced Apoptosis of PC12 Cells Independent of Ceramide Formation,” Neurological Research, Vol. 22, No. 6, 2000, pp. 556-564.
|
[8]
|
H. N. Green and J. W. Westrop, “Hydrogen Peroxide and Tumor Therapy,” Nature, Vol. 181, 1958, pp. 128-129. doi:10.1038/181128a0
|
[9]
|
K. Sugiura, “Effect of Hydrogen Peroxide on Transplanted Rat and Mouse Tumors,” Nature, Vol. 182, 1958, pp. 1310-1311. doi:10.1038/1821310a0
|
[10]
|
J. Fang, T. Sawa, T. Akaike and H. Maeda, “Tumor-Targeted Delivery of Polyethylene Glycol-Conjugated for Antitumor Therapy via Enzymatic Generation of Hydrogen Peroxide,” Cancer Research, Vol. 62, No. 11, 2002, pp. 3138-3143.
|
[11]
|
H. Maeda, L.W. Seymour and Y. Miyamoto, “Conjugates of Anticancer Agents and Polymers: Advantages of Mac-Romolecular Therapeutics in Vivo,” Bioconjugate Chemisry, Vol. 3, No. 5, 1992, pp. 351-362.
|
[12]
|
J. Fang, D. Deng, H. Nakamura, T. Akuta, H. Qin, A. K. Iyer, K. Greish and H. Maeda, “Oxystress Inducing Anti-tumor Therapeutics via Tumor-Targeted Delivery of PEG-Conjugated D-Amino Acid Oxidase,” International Journal of Cancer, Vol. 122, No. 5, 2008, pp. 1135-1144.
doi:10.1002/ijc.22982
|
[13]
|
O. D. Jayakumar, R. Ganguly, A. K. Tyagi, D.K. Chandrasekharan and C. K. K. Nair, “Water Dispersible Fe3O4 Nanoparticles Carrying Doxorubicin for Cancer Therapy,” Journal of Nanoscience and Nanotechnology, Vol. 9, 2009, pp. 6344-6348. doi:10.1166/jnn.2009.1369
|
[14]
|
L. W. Seymour, Y. Miyamoto, H. Maeda, M. Brereton, J. Strohalm, K. Ulbrich and R. Duncan, “Influence of Mo-Lecular Weight on Passive Tumor Accumulation of a Soluble Macromolecular Drug Carrier,” European Journal of Cancer, Vol. 31A, No. 5, 1995, pp. 766-770.
doi:10.1016/0959-8049(94)00514-6
|
[15]
|
L. W. Seymour, S. P. Olliff, C. J. Poole, P. G. De Takats, R, Orme, D. R. Ferry, H. Maeda, T. Konno and D. J. Kerr, “A Novel Dosage Approach for Evaluation of SMANCS [Poly-(strene-co-maleyl-half-n-butylate)-neocarzinostatin] in the Treatment of Primary Hepatocellular Carcinoma,” International Journal of Oncology, Vol. 12, No. 6, 1998, pp. 1217-1223.
|
[16]
|
J. Grabis, G. Heidemane and D. Rasmane, “Preparation of Fe33O4 and γ-Fe2O3 Nanoparticles by Liquid and Gas Phase Processes,” Materials Science (medziagotyra), Vol. 14, 2008, pp. 292-295.
|
[17]
|
J. D. Choi, “The Nature of N-5 Reactivity in Flavins and Inhibitor Complexes,” 1978.
http://etd.lib.ttu.edu/theses/available/etd-04102009-1295015070716/unrestricted/31295015070716.pdf
|
[18]
|
T. Watanabe, Y. Motomura and T. Suga, “A New Colori-Metric Determination of and Urate Oxidase Activity,” Analytical Biochemistry, Vol. 86, No. 1, 1978, pp. 310-315. doi:10.1016/0003-2697(78)90347-0
|
[19]
|
D. K. Chandrasekharan, V. T. Kagiya and C. K. K. Nair, “Radiation Protection by 6-Palmitoyl Ascorbic Acid-2-Glucoside: Studies on DNA Damage in Vitro, ex Vivo, in Vivo and Oxidative Stress in Vivo,” Journal of Radiation Research, Vol. 50, No. 3, 2009, pp. 203-212.
doi:10.1269/jrr.08090
|
[20]
|
H. Cerda, H. Delincee, H. Haine and H. Rupp, “The DNA ‘Comet Assay’ as a Rapid Screening Technique to Control Irradiated Food,” Mutation Research, Vol. 375, No. 2, 1997, p. 167. doi:10.1016/S0027-5107(97)00012-2
|
[21]
|
K. Konca, A. Lankoff, A. Banasik, H. Lisowka, T. Kuszewski, S. Gozdz, Z. Koza and A. Wojcik, “Across Platform Public Domain PC Image Analysis Programme for the Comet Assay,” Mutation Research, Vol. 534, No. 1-2, 2003, pp. 15-20.
|
[22]
|
D. Sandeep and C. K. K. Nair, “Protection of DNA and Membrane from γ-Radiation Induced Damage by the Extract of Acorus calamus Linn.: An in Vitro Study,” Environmental Toxicology and Pharmacology, Vol. 29, No. 3, 2010, pp. 302-307. doi:10.1016/j.etap.2010.02.006
|
[23]
|
G. G. Nair and C. K. K. Nair, “Amelioration of γ-Radiation Induced Genomic Insult and Oxidative Stress in Whole Body Irradiated Swiss Albino Mice by Sesamol,” International Journal of Low Radiation, Vol. 8, No. 1, 2011, pp. 20-34.
|
[24]
|
S. Wada, T. V. Khoa, Y. Kobayashi, T. Funayama, K. Yamamoto, M. Natsuhor and N. Ito, “Detection of Radiation-Induced Apoptosis Using the Comet Assay,” Journal of Veterinary Medical Science, Vol. 65, No. 11, 2003, pp. 1161-1166. doi:10.1292/jvms.65.1161
|
[25]
|
R. C. Wilkins, D. Wilkinson, H. P. Maharaj, P. V. Bellier, M. B. Cybulski and J. R. McLean, “Differential Apoptotic Response to Ionizing Radiation in Subpopulations of Human White Blood Cells,” Mutation Research, Vol. 513, No. 1-2, 2002, pp. 27-36.
|
[26]
|
T. Sawa, J. Wu, T. Akaike and H. Maeda, “Tumor-Targeting Chemotherapy by a Xanthine Oxidase-Polymer Conjugate That Generates Oxygen-free Radicals in Tumor Tissue,” Cancer Research, Vol. 60, 2000, pp. 666-671.
|